We are live on ! Find out more
PMEF

Point72 Middle East FZE Portfolio holdings

AUM $3.38B
1-Year Est. Return 14.09%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+14.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.6B
AUM Growth
+$670M
Cap. Flow
+$559M
Cap. Flow %
15.51%
Top 10 Hldgs %
16.11%
Holding
2,193
New
624
Increased
517
Reduced
333
Closed
712

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$124M
2
CI icon
Cigna
CI
+$26.3M
3
LOW icon
Lowe's Companies
LOW
+$26M
4
V icon
Visa
V
+$24.5M
5
UNH icon
UnitedHealth
UNH
+$23.8M

Sector Composition

Rank Sector Weight
1 Technology 8.68%
2 Healthcare 7.32%
3 Consumer Discretionary 7.26%
4 Financials 6.68%
5 Industrials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMPR icon
1826
Kemper
KMPR
$1.54B
-1,927
Closed -$105K
KOD icon
1827
Kodiak Sciences
KOD
$2.64B
-3,318
Closed -$20.6K
KTB icon
1828
Kontoor Brands
KTB
$4.14B
-9,581
Closed -$464K
KURA icon
1829
Kura Oncology
KURA
$882M
-522
Closed -$6.38K
KVHI icon
1830
KVH Industries
KVHI
$151M
-3,766
Closed -$42.9K
LAB icon
1831
Standard BioTools
LAB
$309M
-9,314
Closed -$18.2K
LASR icon
1832
nLIGHT
LASR
$2.84B
-7,246
Closed -$73.8K
LCTX icon
1833
Lineage Cell Therapeutics
LCTX
$283M
-22,987
Closed -$34.5K
LDOS icon
1834
Leidos
LDOS
$17.7B
-23,041
Closed -$2.12M
LESL icon
1835
Leslie's
LESL
$12.4M
-3,603
Closed -$793K
LGND icon
1836
Ligand Pharmaceuticals
LGND
$5.76B
-22
Closed -$1.59K
LH icon
1837
CALL
Labcorp
LH
$26.1B
-931
Closed -$184K
LH icon
1838
Labcorp
LH
$26.1B
-10,469
Closed -$2.06M
LH icon
1839
PUT
Labcorp
LH
$26.1B
-1,280
Closed -$252K
LHX icon
1840
L3Harris
LHX
$53.3B
-48,524
Closed -$9.28M
LII icon
1841
Lennox International
LII
$14.9B
-2,671
Closed -$671K
LITE icon
1842
Lumentum
LITE
$63.8B
-45,899
Closed -$2.48M
LIVN icon
1843
LivaNova
LIVN
$4.33B
-14,236
Closed -$620K
LLY icon
1844
CALL
Eli Lilly
LLY
$1.08T
-10,100
Closed -$3.47M
LMNR icon
1845
Limoneira
LMNR
$254M
-3,309
Closed -$55.1K
LNC icon
1846
Lincoln National
LNC
$8.51B
-10,960
Closed -$246K
LNT icon
1847
Alliant Energy
LNT
$17.8B
-17,651
Closed -$943K
LNZA icon
1848
LanzaTech
LNZA
$69M
-23
Closed -$8.93K
LOB icon
1849
Live Oak Bancshares
LOB
$1.98B
-5,278
Closed -$129K
LOGI icon
1850
Logitech
LOGI
$14.8B
-14,712
Closed -$854K

Similar funds

Point72 Middle East FZE's Q2 2023 Portfolio in Review

As of Q2 2023, Point72 Middle East FZE held 2,193 positions worth $3.6B, up 23% from $2.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Point72 Middle East FZE deployed $559M of net new capital in Q2 2023, opening 624 new positions and adding to 517 existing holdings. Its largest new stake was AbbVie: 129,855 shares worth $17.5M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Honeywell, an estimated $21.6M trimmed.

  • Point72 Middle East FZE's largest Q2 2023 buy was AbbVie: 129,855 shares worth $17.5M.
  • Point72 Middle East FZE added most to iShares Russell 2000 ETF in Q2 2023, an estimated $50.1M increase.
  • Point72 Middle East FZE's biggest Q2 2023 reduction was Honeywell, cutting an estimated $21.6M.
  • Point72 Middle East FZE fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $124M.
  • Point72 Middle East FZE's ten largest holdings make up 16% of its $3.6B portfolio in Q2 2023.
  • Point72 Middle East FZE opened 624 new positions and closed 712 in Q2 2023.
  • Point72 Middle East FZE's portfolio value rose 23% quarter-over-quarter to $3.6B.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.